Literature DB >> 11475798

The muscarinic receptor subtypes in human blood vessels.

L Walch1, C Brink, X Norel.   

Abstract

Acetylcholine (ACh) may induce the relaxation and the contraction of human blood vessels. These effects involve the activation of muscarinic receptors located on endothelial or smooth muscle cells. In humans and animals, five subtypes of muscarinic receptors (M1-M5) have been identified. In the particular case of human blood vessels, the M3 subtype seems to be prevalent on endothelial cells as well as on smooth muscle cells. However, the M1 subtype may be specific for the pulmonary vascular endothelium. In contrast, the M4 subtype has not been described in human vessels. These conclusions are, however, based on a limited number of studies and further work is needed in this area of research. Although muscarinic receptors may not be the only receptors involved in hypertension, the development of specific agonists for M1 receptors may be useful to counteract any elevation of blood pressure in the pulmonary circulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11475798

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  16 in total

Review 1.  The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation.

Authors:  Valentin A Pavlov; Hong Wang; Christopher J Czura; Steven G Friedman; Kevin J Tracey
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

2.  Coralsnake Venomics: Analyses of Venom Gland Transcriptomes and Proteomes of Six Brazilian Taxa.

Authors:  Steven D Aird; Nelson Jorge da Silva; Lijun Qiu; Alejandro Villar-Briones; Vera Aparecida Saddi; Mariana Pires de Campos Telles; Miguel L Grau; Alexander S Mikheyev
Journal:  Toxins (Basel)       Date:  2017-06-08       Impact factor: 4.546

3.  Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein.

Authors:  Virginia Andrea Pujol Lereis; Francisco Javier Hita; Mauro Darío Gobbi; Marcela Gomez Verdi; María Cecilia Rodriguez; Rodolfo Pedro Rothlin
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

4.  GROWTH AND CHARACTERIZATION OF A TISSUE-ENGINEERED CONSTRUCT FROM HUMAN CORONARY ARTERY SMOOTH MUSCLE CELLS.

Authors:  A A Sulgin; T N Sidorova; V Y Sidorov
Journal:  Biulleten Sib Meditsiny       Date:  2020

5.  Actin microdomains on endothelial cells: association with CD44, ERM proteins, and signaling molecules during quiescence and wound healing.

Authors:  P V Jensen; L-I Larsson
Journal:  Histochem Cell Biol       Date:  2004-04-22       Impact factor: 4.304

Review 6.  Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans.

Authors:  I Wessler; C J Kirkpatrick
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

7.  Muscarinic Receptor Activation Affects Pulmonary Artery Contractility in Sheep: The Impact of Maturation and Chronic Hypoxia on Endothelium-Dependent and Endothelium-Independent Function.

Authors:  Michael Giang; Demosthenes G Papamatheakis; Dan Nguyen; Ricardo Paez; Carla Blum Johnston; Joon Kim; Alexander Brunnell; Quintin Blood; Ravi Goyal; Lawrence D Longo; Sean M Wilson
Journal:  High Alt Med Biol       Date:  2016-06       Impact factor: 1.981

8.  Blood Pressure Regulation Evolved from Basic Homeostatic Components.

Authors:  Alon Botzer; Yoram Finkelstein; Ron Unger
Journal:  Biomedicines       Date:  2021-04-25

Review 9.  Loranthus ferrugineus: a Mistletoe from Traditional Uses to Laboratory Bench.

Authors:  Omar Z Ameer; Ibrahim M Salman; Ko Jin Quek; Mohd Z Asmawi
Journal:  J Pharmacopuncture       Date:  2015-03

10.  Impaired vascular responses to parasympathetic nerve stimulation and muscarinic receptor activation in the submandibular gland in nonobese diabetic mice.

Authors:  Ellen Berggreen; Krister Nyløkken; Nicolas Delaleu; Hamijeta Hajdaragic-Ibricevic; Malin V Jonsson
Journal:  Arthritis Res Ther       Date:  2009-02-06       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.